Related Experiment Video

Updated: Aug 29, 2026

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors
14:55

Production and Purification of Non Replicative Canine Adenovirus Type 2 Derived Vectors

Published on: December 3, 2013

[Conditionally replicative adenoviruses: a second wind for cancer gene therapy]

Jacques Grill1, Birgit Geoerger, Martine Lamfers

  • 1UPRES EA 3535, Pharmacologie et nouveaux traitements des cancers, Institut Gustave-Roussy, 94805 Villejuif. grill@igr.fr

Bulletin Du Cancer
|January 13, 2004
PubMed

Insights

Cancer gene therapy faces challenges with vector delivery and efficacy. Tumor-selective replicating adenoviruses show promise in early clinical trials for improving cancer treatment outcomes.

Area of Science:

  • Oncology
  • Virology
  • Gene Therapy

Context:

  • Cancer gene therapy has shown potential but faces significant hurdles.
  • Current limitations include vector efficacy, specificity, gene diffusion within tumors, and poor vector distribution.
  • These challenges hinder the successful application of gene therapy in cancer treatment.

Purpose:

  • To address the limitations of conventional cancer gene therapy.
  • To explore the development and potential of tumor-selective replicating adenoviruses.
  • To evaluate the early clinical promise of these novel viral vectors.

Summary:

  • Tumor-selective replicating adenoviruses have been developed to overcome key challenges in cancer gene therapy.
  • These agents aim to improve vector delivery, specificity, and therapeutic effect diffusion within tumors.
  • Early clinical results for these adenoviruses are promising, suggesting potential therapeutic benefits.

Impact:

  • These novel adenoviruses may offer improved treatment options for cancer patients.
  • Further complementary studies are required to fully establish their role in the cancer therapeutic arsenal.
  • Successful implementation could enhance the efficacy and safety of gene therapy for various cancers.

More Related Videos

Quantification of Adeno-Associated Viral Genomes in Purified Vector Samples by Digital Droplet Polymerase Chain Reaction04:43

Quantification of Adeno-Associated Viral Genomes in Purified Vector Samples by Digital Droplet Polymerase Chain Reaction

Published on: October 11, 2024

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Gene Therapy01:22

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy01:22

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...